Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05306665 · ClinicalTrials.gov registry record · NA

PREventing Pain After Surgery

A NA study of Spondylolisthesis and Spinal Stenosis, sponsored by Brigham and Women's Hospital.

Recruiting
Registry status
NA
Development phase
140
Enrollment target
1
Study location

NCT05306665: Recruiting NA study of Spondylolisthesis and Spinal Stenosis, sponsored by Brigham and Women's Hospital.

NCT05306665 is a NA study of Spondylolisthesis and Spinal Stenosis that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 140 participants, roughly in line with the 145-participant average among 18 other Spondylolisthesis trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05306665, a NA study of Spondylolisthesis and Spinal Stenosis, is actively recruiting participants, sponsored by Brigham and Women's Hospital.

RECRUITING
Registry status
NA
Development phase
140 participants
Enrollment target
1
Study location

Study Summary

The present study aims to adapt and modify a brief presurgical Acceptance and Commitment Therapy (ACT) intervention aimed at preventing the transition to Chronic Post-Surgical Pain (CPSP) and reducing long-term opioid use. Investigators will then assess the acceptability, feasibility, and preliminary efficacy of the finalized intervention to prevent the transition to CPSP and reduce post-surgical opioid use six months following lumbar spine surgery. Finally, investigators will identify psychosocial and psychophysical phenotypes associated with response to this intervention.

Primary Outcome

Treatment Helpfulness Questionnaire (THQ); Item assesses the perceived helpfulness of the ACT workshop and is rated from -5 (extremely harmful) to 5 (extremely helpful).

Interventions

  • BEHAVIORAL ACT intervention

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Chestnut Hill

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2023-01-13
Est. Completion 2026-08-01
Phase NA
Brigham and Women's Hospital

937 total trials

What NCT05306665 shows while recruiting

NCT05306665 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 145-participant average among 18 other Spondylolisthesis trials with a reported enrollment target.

The record links to 6 conditions, with Spondylolisthesis appearing as the primary indexed condition, and to 1 intervention - of which ACT intervention is the first listed.

NCT05306665 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05306665 about?

NCT05306665 is a clinical study titled "PREventing Pain After Surgery". The present study aims to adapt and modify a brief presurgical Acceptance and Commitment Therapy (ACT) intervention aimed at preventing the transition to Chronic Post-Surgical Pain (CPSP) and reducing long-term opioid use. Investigators will then assess the acceptability, feasibility, and preliminar...

What is the current status of trial NCT05306665?

This trial is currently recruiting. It is a NA study. The enrollment target is 140 participants. The study started on 2023-01-13. Estimated completion is 2026-08-01.

What conditions does trial NCT05306665 study?

This clinical trial studies the following conditions: Spondylolisthesis, Spinal Stenosis, Spondylosis, Pain, Back, Back Injuries.

What interventions are being tested in trial NCT05306665?

The interventions under investigation include: ACT intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05306665?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05306665 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spondylolisthesis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05306665's enrollment target sits among peer trials

140 7th of 18 higher than 12 of 18 other Spondylolisthesis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spondylolisthesis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01419561 · 140 participants · Phase 2

    Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)

  • NCT01624805 · 140 participants · Phase 2

    Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome

  • NCT02369770 · 140 participants · NA

    Sensory-Motor Rehabilitation Post Stroke

  • NCT02455193 · 140 participants · NA

    Neuronal Effects of Exercise in Schizophrenia

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05306665, the US trial registry maintained by the National Library of Medicine. NCT05306665 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.